Tue, 31st Jul 2018 17:51
LONDON (Alliance News) - GloxoSmithKline PLC said that a person closely associated with Chief Strategy Officer David Redfern bought 3,930 shares in the company at 1,575 pence each in two transactions on Tuesday.
GlaxoSmithKline shares closed up 1.1% at 1,581.60p each.
April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set ...
April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set ...
(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut ...
April 30 (Reuters) - Haleon, the world's largest standalone consumer healthcare firm, will shut its UK production site which makes Sensodyne toothpa...
April 25 (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related...
Glaxosmithkline (GSK)